These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 819182)
1. Levamisole: a synthetic immunopotentiator under evaluation. Hadden JW Clin Bull; 1975; 5(1):32-3. PubMed ID: 819182 [No Abstract] [Full Text] [Related]
2. [Antitumor activity and the effect on immunogenesis of combinations of rubomycin and carminomycin with levamisole]. Vatin AE; Filatov PP Antibiotiki; 1982 Apr; 27(4):284-7. PubMed ID: 6896414 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)]. Sakharchuk II; Skakal'skaia LM Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185 [No Abstract] [Full Text] [Related]
4. Levamisole as an immunostimulant. Pár A Ther Hung; 1980; 28(4):163-7. PubMed ID: 6782693 [No Abstract] [Full Text] [Related]
5. [Clinical use of levamisole - perspectives and warnings]. Farber NA Ter Arkh; 1980; 52(1):95-100. PubMed ID: 7368132 [No Abstract] [Full Text] [Related]
8. Letter: Levamisole and the immune response. N Engl J Med; 1973 Nov; 289(21):1148-9. PubMed ID: 4585358 [No Abstract] [Full Text] [Related]
9. [Levamisole - a new immunostimulant]. Rachkov SM Ter Arkh; 1976; 48(11):133-8. PubMed ID: 1088219 [No Abstract] [Full Text] [Related]
10. Levamisole in cancer treatment: modifications in time of cellular immunity. (Preliminary report). Luporini G; Fraschini P; Labianca R; Negri R Boll Ist Sieroter Milan; 1979 Nov; 58(5):435-9. PubMed ID: 576007 [TBL] [Abstract][Full Text] [Related]
11. Levamisole in the modulation of the immune response: the current experimental and clinical state. Symoens J; Rosenthal M J Reticuloendothel Soc; 1977 Mar; 21(3):175-221. PubMed ID: 142150 [No Abstract] [Full Text] [Related]
12. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy. Urist MM; Boddie AW; Townsend CM; Holmes EC J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057 [TBL] [Abstract][Full Text] [Related]
13. [Clinico-immunological evaluation of the levamisole treatment of chronic glomerulonephritis patients]. Pyrig LA; Kolesnik NA Vrach Delo; 1983 Mar; (3):95-8. PubMed ID: 6858119 [No Abstract] [Full Text] [Related]
14. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections. Grimaldi GF; Moriearty PL; Hoff R Clin Exp Immunol; 1980 Aug; 41(2):237-42. PubMed ID: 7438553 [TBL] [Abstract][Full Text] [Related]
15. [Therapy of myocarditis with levamisole]. Niedworok J; Goch JH; Kulig H; Tkaczewski W; Kuklewicz C Z Gesamte Inn Med; 1986 Aug; 41(16):456-8. PubMed ID: 3776260 [TBL] [Abstract][Full Text] [Related]
18. [Metastasis. Natural history and therapeutic data]. Scolozzi R; Boccafogli A; Furlani RF; Vicentini L Recenti Prog Med; 1982 Apr; 72(4):446-81. PubMed ID: 6216563 [No Abstract] [Full Text] [Related]
19. Cellular immune modulation after a single high dose of Levamisole in patients with carcinoma. Lewinski UH; Mavligit GM; Hersh EM Cancer; 1980 Nov; 46(10):2185-94. PubMed ID: 7427861 [TBL] [Abstract][Full Text] [Related]
20. [Effect of prodigiozan, levamisole and methyluracil on delayed hypersensitivity against a background of immunosuppressor use]. Riabchinskaia LA; Lazareva DN Antibiotiki; 1983 Jul; 28(7):510-4. PubMed ID: 6625546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]